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Abstract
The simultaneous measurement of T cell function with recovery of individual T cells would 
greatly facilitate characterizing antigen-specific responses both in vivo and in model systems. We 
have developed a microraft array methodology that automatically measures the ability of 
individual T cells to kill a population of target cells and viably sorts specific cells into a 96-well 
plate for expansion.
A human T cell culture was generated against the influenza M1p antigen. Individual microrafts on 
a 70 × 70 array were loaded with on average 1 CD8+ cell from the culture and a population of 
M1p presenting target cells. Target cell killing, measured by fluorescence microscopy, was 
quantified in each microraft. The rates of target cell death among the individual CD8+ T cells 
varied greatly; however, individual T cells maintained their rates of cytotoxicity throughout the 
time course of the experiment enabling rapid identification of highly cytotoxic CD8+ T cells. 
Microrafts with highly active CD8+ T cells were individually transferred to wells of a 96-well 
plate, using a needle-release device coupled to the microscope. Three sorted T cells clonally 
expanded. All of these expressed high-avidity T cell receptors for M1p/HLA*02:01 tetramers, and 
2 of the 3 receptors were sequenced.
While this study investigated single T cell cytotoxicity rates against simple targets with subsequent 
cell sorting, future studies will involve measuring T cell mediated cytotoxicity in more complex 
cellular environments, enlarging the arrays to identify very rare antigen specific T cells, and 
measuring single cell CD4+ and CD8+ T cell proliferation.
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Introduction
Antigen-specific, cytotoxic CD8+ T cell responses are an essential component in the 
adaptive immune system’s ability to control both viral infections and cancer. Multiple types 
of experiments designed to quantify the number of antigen-specific CD8+ T cells and 
measure the cytotoxic activity of a T cell population are routinely used to characterize CD8+ 
responses; however, many standard immune monitoring assays have limitations with respect 
to sample size (or cell number) requirements, sample processing, assay time or cost that 
make detailed characterization of immune responses problematic.
To measure the fraction of antigen-specific CD8+ T cells in a T cell population, which is 
important in measuring immune responses and immunodominance in vivo as well as in the 
expansion of antigen-specific T cells in culture, peptide/MHC (major histocompatibility 
complex) tetramers are often used.1, 2 Tetramer-based enumeration is expensive however, 
and requires a unique tetramer per antigen to be tested, which is problematic particularly in 
the field of personalized cancer neo-antigen discovery.3, 4 Furthermore, this assay, by itself, 
does not provide a measurement of T cell effector function or activity. For functional 
assessment of individual T cells in a bulk population, intracellular cytokine flow cytometry,5 
which can be coupled with tetramer enumeration,6-8 or ELISPOT analysis can be 
employed.9, 10 These methods report cytokine secretion in response to a stimulus, such as T 
cell receptor (TCR) binding to its cognate peptide/MHC. Compared to cytokine secretion, a 
more direct measure of cytotoxicity is the measurement of cell surface expression of CD107, 
which is contained in T cell cytotoxic granules and whose surface expression is associated 
with cytotoxicity.11 While all of these methods give information on T cell function, none of 
them directly measure individual T cell mediated killing, the most significant property of 
CD8+ T cells, nor do they provide any data regarding the time dependence as the 
measurement is only made at the conclusion of the experiment.
Beyond the quantification of antigen-specific T cells and measurements of their function, 
there is often a need for clonal expansion of individual T cells to allow further 
characterization or to produce clonal populations that can be used as probes for monitoring 
antigen presentation under different situations and in different cell types. Clonal T cell 
populations can be expanded using limiting dilution methods and by fluorescence activated 
cell sorting (FACS); however, both methods have drawbacks. Limiting dilution has no 
selection method so, while it is often a more efficient method for clonal T cell expansion 
compared to FACS, many expanded clonal populations do not have the antigen-specific 
properties of interest.12-14 FACS can provide specific cell sorting based upon the expression 
of cell surface markers, including TCRs specific to peptide/MHC tetramers.15, 16 FACS 
negatively affects cell viability however because of the temperature and pressures applied to 
the T cells in the cell sorter.17 Although cell viability can be furthermore reduced by the 
enhanced activation of Src kinases through ligation of the TCR with multimeric 
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peptide/MHC tetramers; although, some of the deficiencies with peptide/MHC induced cell 
death can be mitigated using reversible peptide/MHC tetramers.18 Surface CD107 
expression on T cells after antigenic stimulation has also been used to isolate individual 
CD8+ T cells.19 However, this method does not directly measure cell killing, and the 
measurement is only made at the time of sorting, whereas CD107 expression varies with 
time.
In this project we have developed a methodology to identify, isolate and clonally expand 
antigen specific CD8+ T cells based upon the longitudinal measurement of their killing of 
antigen expressing target cells. The methodology was developed using microraft arrays with 
each microraft designed to contain a population of fluorescently labeled antigen-presenting 
target cells and 1 CD8+ T cell. A cytotoxicity dye in the media allowed for the measurement 
of target cell death over time. Over the 6-h time course of the experiments, there was 
tremendous heterogeneity in the rate of target cell killing by individual CD8+ T cells; 
however, the rates of killing remained relatively constant for single cells, allowing for the 
identification of highly cytotoxic CD8+ T cells in as little as 2 h. Microrafts that contained a 
CD8+ T cell and showed a high rate of target cell death were transferred from the array to a 
well in a 96-well plate using a previously designed needle-release device, and the sorted T 
cells were clonally expanded for further characterization including measurement of TCR 
affinity to a peptide/MHC tetramer and sequencing of the TCRα and TCRβ CDR3 regions.
Experimental
Detailed descriptions of the materials and methods used in these experiments are provided in 
the supplementary methods section. Brief descriptions of the experimental methods are 
provided below.
Fabrication of microraft arrays
Microraft arrays, consisting of PDMS microwells containing releasable, magnetic elements 
were created using previously described methods.20-22 The arrays for this series of 
experiments contained 4900 microwells (70 × 70 array) constructed on SU-8 pillars (200 × 
200 × 200 μm, spaced 100 μm apart) coated with poly(styrene-co-acrylic acid) (PS-AA) co-
mixed with γFe2O3 nanoparticles.21
Microscopy Setup
An MVX10 MacroView upright microscope (Olympus, Center Valley, PA) equipped with an 
ORCA-Flash 4.0 CMOS camera (Hamamatsu, Bridgewater, NJ) was used to acquire bright 
field and fluorescence micrographs. The MVX10 MacroView was fitted with a PS3H122 
Motorized Focus Drive and a H138A motorized XY translational stage manipulated by a 
ProScan H31 Controller and a PJ2J100 joystick (Prior Scientific Inc., Rockland, MA). A 
Lambda 10-3 optical filter changer was utilized to control an emission filter wheel (LB10-
NWE), an excitation filter wheel with SmartShutter (LB10-NWIQ) and a stand-alone 
SmartShutter shutter (IQ25-SA) (Sutter Instrument, Novato, CA). A sedat filter set (89000 – 
ET – Sedat Quad; Chroma Technology Corp, Bellows Falls, VT) containing 5 excitation 
filters (350 ± 50 nm, 402 ± 15 nm, 490 ± 20 nm, 555 ± 25 nm, 645 ± 30 nm), 4 emission 
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filters (455 ± 50 nm, 525 ± 36 nm, 605 ± 52 nm, 705 ± 72 nm) and a multiband dichroic 
enabled measurement of fluorescence in the blue, green, red and far red wavelengths. A 
lumen 200 arc lamp (Prior Scientific Inc., Rockland, MA) provided light for fluorescence 
excitation. All microscopy equipment was controlled by custom software written in 
MATLAB (MathWorks, Natick, MA) and using a Micro-Manager (Open Imaging, San 
Francisco, CA) core.23, 24 A custom-made incubator was made to fit around the microscopy 
set-up to regulate temperature, humidity and CO2 concentration during time-lapse 
microscopy experiments.
Preparation of microraft arrays for the cytotoxicity assays
Prior to experiments on the microraft array, the array was treated for 5 min in a plasma 
cleaner (Harrick Plasma, Ithaca, NY). The array was then washed with 100% ethanol and 
subsequently washed ×5 with PBS. The microraft array was coated in bovine gelatin in PBS 
and incubated at. The gelatin solution was aspirated and the array was washed with PBS 
before plating cells.
Generation of dendritic cells (DCs) from CD34+ progenitors
Dendritic cells were differentiated from CD34+ cells using a modification of a previously 
described method.25 CD34+ cells were isolated from cryopreserved leukapheresis products 
obtained from the Hematopoietic Progenitor Cell Laboratory at UNC Hospitals using the 
CD34 Microbead Kit UltraPure (Miltenyi Biotec). CD34+ cells were incubated for 12 d in 
CTS AIM V media with 10% human AB serum (complete media, CM), supplemented with 
GM-CSF, Flt3-ligand, SCF and IL-4 as described in the supplemental methods to yield 
immature DCs that were cryopreserved for future use. Immature DCs were differentiated 
into mature DCs by incubation with GM-CSF, IL-4 and TNF-α for 2 d and GM-CSF, IL-4, 
TNF-α, IFN-α and IL-6 for 2 d. Matured DCs were co-incubated with peptides (M1p or 
PR1) for at least 18 h.
Generation of cytotoxic T lymphocytes (CTLs)
PBMCs were isolated from a leukapheresis product from the same donor using Ficoll-Paque 
PLUS, and monocytes were removed by plastic adherence. Non-adherent cells (NADs) were 
collected, and CD8+ cells from the NAD fraction were isolated by magnetic separation using 
the CD8+ T cell isolation kit (Miltenyi Biotec).
The cytotoxic T lymphocyte (CTL) culture was initiated by incubating the CD8+ T cells 
with M1p pulsed DCs in CM supplemented with IL-21.26 After a 3 d incubation, the cells 
were supplemented with CM plus IL-7 and IL-15 every 2 d. CTLs were restimulated with 
M1p-pulsed DCs 11 d after culture initiation in CM containing IL-21, IL-7 and IL-15. IL-2 
was added 19 d after initiation of the culture.26 The CTLs were restimulated 21 and 34 d 
after culture initiation and were cryopreserved in aliquots 41 d after initiation of the culture.
Tetramer analysis
Ten μL of APC-labeled M1p/HLA-A*02:01 tetramer or negative tetramer was added to each 
sample with PE-Cy7-anti-CD8 antibody and a FITC labeled lineage mix of CD4, CD14, 
CD16 and CD19 antibodies. The cells were washed and resuspended. DAPI live/dead dye 
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was added. Sample acquisition was performed on a FACSCanto flow cytometer (BD 
Biosciences) and data was analyzed using FlowJo version 7.6.5 (FlowJo LLC, Ashland, 
OR).
Bulk culture cytotoxicity assay
Cyropreserved CTLs were restimulated with M1p pulsed DCs in CM supplemented with 
IL-2, IL-7 and IL-15 4 d prior to the cytotoxicity assay. Differentiated DCs (targets, T) were 
stained with DDAO-SE in DPBS, incubated overnight with M1p or PR1 peptide, washed 
and resuspended. CTLs (effectors, E) were stained with Cell Tracker Green CMFDA dye 
and resuspended in CM. CTLs were co-incubated with DCs at 1:1 E:T ratio or a 2:1 E:T 
ratio. After 6 h, cells were resuspended, treated with LIVE/DEAD Fixable Violet Dead Cell 
Stain and fixed in 2% formaldehyde. Cells were analyzed on a Miltenyi MACSQuant flow 
cytometer (Miltenyi Biotec) with data analysis using FlowJo version 7.6.5.
Restimulation of CTLs and isolation of CD8+ cells prior to plating on the microraft arrays
Cryopreserved CTLs were thawed and restimulated with M1p pulsed DCs. After 3 d, the 
CTLs were isolated using the CD8+ T cell isolation kit and maintained in CM supplemented 
with IL-7, IL-15 and IL-2. CD8+ T cells were plated on microraft arrays 2 to 3 d later.
Single T cell cytotoxicity assay
The single cell cytotoxicity assay was constructed in a similar method to that reported by 
Varadarajan et al.27 DCs were pulsed with either M1p or PR1 peptides. Both sets of DCs 
were stained with Hoechst 33342 and Sytox Green prior to plating. Cells were deposited on 
microraft arrays in phenol-red free RPMI 1640 supplemented with human AB serum, 
penicillin, streptomycin and HEPES. For each cytotoxicity assay, two microraft arrays were 
prepared: one with M1p pulsed DCs added and the other with PR1 pulsed DCs. DCs were 
added at cell:microraft ratios of 30:1. Arrays were centrifuged to pull the DCs into the 
microrafts, and the media was aspirated. CD8+ T cells from the M1p culture were stained 
with CellTracker Deep Red and Sytox Green and added to both arrays at a cell:microraft 
ratio of 1:1. The arrays were again centrifuged and the media was aspirated. Culture media 
containing Sytox Green was placed over each array, and each array was covered with a cover 
slip. Arrays were imaged every 30 min for 6 h while in the incubator housing the 
microscope.
Image acquisition
A customized MATLAB program controlled the microscope to acquire bright field and 
fluorescence images of the microraft array at designated time points. A graphical user 
interface (GUI) was designed to permit input of user-selected parameters such as 
fluorescence channel selection, camera exposure, microraft array geometry, microraft array 
numbers and time-lapse conditions.28, 29 A 5% overlap between imaged fields of view was 
used in all experiments.
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Image processing and analysis
In parallel with the image acquisition, the MATLAB program processed and analyzed the 
acquired images. The bright field images were used to identify individual microraft 
locations. Flat-field correction was performed on each bright field image to correct for 
uneven illumination intensity.30 Otsu’s method was then used to calculate a threshold for 
each image, and the image was converted to binary.31 The binary images were processed to 
fill the interior of each microraft border and remove any resulting objects that were larger 
than 1.5× or smaller than 0.5× the microraft size eliminating debris. The positions of all 
microraft were identified at each time point.
Fluorescence images were processed in a similar fashion. A top hat filter was applied with a 
disk structuring element having a radius twice the nominal diameter of a cell to remove 
background fluorescence.32, 33 Otsu’s method was used to determine a threshold for each 
image, and the threshold was applied to convert each image to binary.31 The pixel locations 
and intensity values of each fluorescence image were determined for each individual 
microraft. A watershed algorithm was applied to each image in the far red channel 
(corresponding to cells stained with CellTracker Deep Red) to count the number of 
individual cells on each microraft.34-36
Selection of cells for release
The locations of individual microrafts were determined using the image processing and 
analysis software. Microrafts containing a single CD8+ cell were using CellTracker Deep 
Red fluorescence. These microrafts were sorted based on the increase in Sytox Green 
fluorescence intensity. Automatically identified microrafts were re-screened after gelatin 
encapsulation to ensure that a single CellTracker Deep Red-positive cell remained on the 
microraft.
Microraft/cell release and transfer to a 96-well plate
Upon completion of the cytotoxicity assay, the arrays were overlaid with a thin layer of 
gelatin as described previously.20 The incubator surrounding the microscope was cooled to 
24°C just prior to gelatin overlay of the array. The culture media above the array was 
replaced with 5 wt% bovine gelatin in PBS and the array was centrifuged. The array was 
then incubated for 10 min at 37°C, washed and then incubated at 4°C for 5 min to solidify 
the gelatin within the microrafts. Cold (4°C) culture media was overlaid onto the arrays. 
Previous experiments using the microraft array configuration and gelatin encapsulation have 
shown that 97.8% of cells remain in their initial microwells throughout the entire gelatin 
encapsulation and release process.20
Microraft isolation was performed by actuating a small needle (10 μm tip, 100 μm base, 5 
mm long) to puncture the PDMS of the microraft array and eject individual microrafts as 
described previously.20-22 Released rafts were then captured by a magnetic wand mounted 
on a computer controlled 3-axis motor and deposited into a 96-microwell plate as described 
previously.20
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Preparation of feeder cells for T cell expansion
PBMCs were isolated from 3 different buffy coats using Ficoll-Paque PLUS or Lymphoprep 
and irradiated at 35 Gy. Equal numbers of PBMCs from each buffy coat were combined in 
CM with IL-7, IL-15 and IL-2 and plated at a concentration of 1 × 105/well in 96 well round 
bottom plates.
Limiting dilution
CD8+ CTLs were serially diluted in CM to 5 cells/mL. One hundred μL was added to each 
well of a 96 well plate containing feeder cells, for an expected concentration of 0.5 CTLs/
well.
T cell expansion
Microrafts containing selected CTLs were isolated as described above in to 96-well plates 
containing feeder cells. Cells released from the microrafts and cells plated by limiting 
dilution were expanded in parallel using minor modifications of the protocol described by 
Perna el al.37 OKT3 antibody was added 2 to 3 d after plating the cells, and the cells were 
fed weekly by adding CM supplemented with IL-7, IL-15, IL-2 and OKT3 antibody. 
Expanding single cell clones were transferred to 24 well plates between d 11 and 19 after 
plating. Tetramer staining was performed 2 d later. Tetramer positive clones were further 
expanded with a mix of irradiated PBMCs and an EBV-immortalized lymphoblastoid cell 
line (EBV-LCL) as feeder cells in CM supplemented with IL-2, IL-7, IL-15 and OKT3 
antibody.37 CD8+ cells were isolated using Miltenyi’s CD8+ T cell isolation kit, and cell 
pellets were frozen at −80°C for TCR α and β chain CDR3 sequencing.
Analysis of TCR α- and β-chain CDR3 sequences
RNA was isolated from the B8, D10 and F9 CD8+ T cell clones using Qiagen’s RNeasy 
Micro Kit and stored in aliquots at −80°C. Analysis of TCR α- and β-chain rearrangements 
was performed using multiplex RT-PCR as described by Kim et al. and Seitz et al.38, 39 The 
initial RT-PCR reaction was performed using the OneStep RT-PCR kit.38 TCR β-chains 
were amplified from 1 μL of the RT-PCR product in a run-off reaction, followed by semi-
nested PCR using the Fast Start High Fidelity PCR System. Reactions that produced PCR 
products visible by agarose gel electrophoresis were purified using the Qiagen PCR 
Purification Kit and sequenced.38 TCR α-chains were amplified by nested touchdown PCR 
using 1 μL of the RT-PCR reaction using the Fast Start High Fidelity PCR System.38 PCR 
products were analyzed by agarose gel electrophoresis, purified using the Qiagen PCR 
Purification Kit, and sequenced using the Cα-in primer.38 Sequencing was performed at the 
UNC Genome Analysis Facility (University of North Carolina, Chapel Hill, NC), and 
sequences were analyzed to determine the V and J alleles as well as the CDR3 sequence 
using IMGT/V-Quest (http://www.imgt.org/IMGT_vquest/vquest).40, 41 One clone (F9) did 
not produce readable sequences using the protocol described above, possibly due to poor 
quality RNA. The TCRβ-chain rearrangement of this clone was analyzed using a 
modification of another multiplexed RT-PCR protocol for single cell TCRβ analysis.42
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Statistics
Cytotoxicity results on the microraft array were compared using the nonparametric Mann-
Whitney U-test. All statistics were performed in MATLAB. The k-medoids algorithm was 
used to cluster single CD8+ T cell responses.43 The Kruskal-Wallis test was used to compare 
the clustered groups above. This test is a nonparametric version of a one-way ANOVA test, 
and an extension of the Mann-Whitney U test to more than 2 groups. A multiple comparison 
test was used to identify which groups had a statistically significant difference.44
Results and discussion
Microraft arrays for selection of nonadherent cells
Our group and others have developed microarrays for the functional analysis of rare 
cells.27, 45, 46 In this project, we aimed to develop several technological advances to make an 
automated device that could analyze the interactions and changes in multiple cell 
populations simultaneously over time and then viably sort cells of interest for further 
characterization. One of the most important functional characteristics of CD8+ T cells is 
antigen specific cytotoxicity, so the measurement of single-cell cytotoxicity with subsequent 
cell sorting was chosen to be the first immunologic assay developed on the microraft arrays. 
To develop this assay, methods to analyze 2 cell types and 3 fluorescence channels were 
developed, with this initial assay being able to measure the cytotoxic ability of >1,000 
individual T cells against target cells.
The microraft arrays in this study are comprised of a regular pattern (70 × 70) of transparent 
microcarriers or microrafts on which cells are cultured and assayed over time by microscopy 
(Figure 1A, B). The microrafts fabricated from a magnetic polystyrene possess a concave 
surface of 120 μm depth enhancing retention of cells on their surfaces during assay setup 
and performance. After the identification of cells of interest based upon a fluorescent read-
out over time, five percent gelatin in PBS is poured on the array and gelled encapsulating the 
cells within the concave surface of their microraft. To release a selected microraft with cells 
from the array, a microneedle situated under the microscope stage pushes through the PDMS 
membrane underlying the microraft and releases the selected microraft from the array 
(Figure 1C, D). The microraft with gel-encapsulated cell(s) is then readily captured by an 
overlaying magnetic wand dipped into the media above the array (Figure 1E). The wand 
with the captured microraft is then placed into the well of a 96-well plate. The microraft is 
deposited by the dissipation of surface tension forces created by the residual fluid droplet on 
the wand tip and by repulsion of the wand magnet by a block magnet underlying the 96-well 
plate. The microraft is then pulled down to the bottom of the well by the block magnet 
(Figure 1F). Microrafts can be visualized by bright field microscopy, and the release of 
microrafts can also be confirmed by their presence in the 96-well plate and absence on the 
array (Figure 1G, H).
Design of T cell mediated cytotoxicity assay
While the microraft array format can be employed for multiple types of experiments and 
cells, this series of experiments developed an assay for the selection and capture of T cells 
based upon their cytotoxicity.27 The microraft arrays were seeded with autologous DCs 
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(“target” cells) that had been pulsed with either M1p or PR1 peptides and labeled with 
Hoechst dye. Targets were applied to the array at a ratio of 30 cells per microraft (147,000 
cells per array). CD8+ T cells were labeled with CellTracker Deep Red and placed onto the 
array at a cell:microraft ratio of 1:1 in order to maximize the number of microrafts that 
contained a single T cell. Cells settled onto the array in a stochastic manner so that the 
number in each well across the array followed the Poisson distribution.22, 47 By the Poisson 
distribution, roughly 1/3 of the wells (36.8% or 1803 wells) are predicted to possess a single 
CD8+ T cell, 26.4% (1294) are predicted to contain >1 T cell and 36.8% (1803) are expected 
to have 0 T cells. The media overlaying the array contained Sytox Green, a DNA binding 
dye that is membrane impermeable. The assay was intended to identify microrafts that 
contained a single T cell and showed a high rate of cytotoxicity as evidenced by increasing 
green fluorescence over a 6 h time course (Figure 2A-C). Because both the target cells and T 
cells were applied to the media over the microraft array, individual microrafts had different 
numbers and ratios of target and T cells. (Figure 2D, E). Fluorescence images were obtained 
every 30 min for 6 h and the development of green fluorescence over time was measured for 
each microraft. (Figure 2F, G).
M1p Specific T cell culture
To evaluate the microraft cytotoxicity assay, we tested a T cell culture that was generated 
against the influenza M1p antigen. M1p/HLA-A*02:01 tetramer enumeration showed that 
48.4% of CD8+ T cells were specific for M1p (Figure 3A). The bulk culture displayed 
antigen specific cytotoxicity against M1p pulsed autologous DCs compared to autologous 
DCs pulsed with the leukemia associated antigen PR1 (Figure 3B).48
Automated analysis of cytotoxicity on microraft arrays
The analyses performed on the microraft arrays compared development of green 
fluorescence over time in microrafts that contained either 0 or 1 CD8+ T cell. Microrafts 
with 0 T cells were considered the control and reflected the rate of spontaneous target cell 
death over the time of the investigation. A total magnification of 4× was used for scanning 
microrafts, resulting in a pixel size of 1.62 μm/pixel. This magnification was chosen because 
it allowed for easy identification of single cells while maintaining a large field of view to 
minimize image acquisition time. Each 70 × 70 microraft array required 49 images per 
channel at this magnification with a 5% overlap of images. Image acquisition of a single 
array using bright field (100 ms camera exposure) plus 3 fluorescence channels (200 ms 
camera exposure each) required 216 ± 4 s to complete (n = 10). An autofocus algorithm was 
used to maintain focus for each image and required 99 ± 2 s to complete. All of the 
automatically acquired focal planes were accurate to within the microscope objective’s 
depth of field at 4× magnification (±21.8 μm) compared to the manually selected focal 
planes (n = 50). The resulting total microraft array scan time (autofocus and image 
acquisition) was 315 ± 5 s.
In parallel with the image acquisition, the MATLAB program processed and analyzed the 
acquired images. The MATLAB GUI was used to select the desired combination of bright 
field and fluorescence channels for imaging. The processing time of each set of images was 
faster than the microscope stage movement and image acquisition, so no additional time was 
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added to the total scan time. The bright field images were used to identify individual 
microraft locations. Due to the elastomeric nature of PDMS, image analysis was needed to 
accurately locate the exact positions of microrafts on the array. The microraft segmentation 
method consisted of background estimation, flat-field correction, thresholding and 
morphological filtering. The vast majority of microrafts (99.8 ± 0.8%) were correctly 
identified without false positives (n = 100 images, 100-121 microrafts per image). The 
microrafts that were not correctly identified were missed due to debris obscuring the 
microraft.
The fluorescence images were analyzed to determine the intensity, area, position and 
number of cells displaying each fluorophore (Hoechst, Sytox Green and CellTracker Deep 
Red). Top hat filtering and Otsu’s thresholding was applied to each image to produce a 
binary mask of the cells on the microraft array. Within the mask created by each 
fluorophore, the intensity, location and number of pixels was recorded for each microraft. 
The number of T cells on each microraft was counted from the far-red fluorescence after 
implementation of the watershed algorithm. Of 401 microrafts manually examined, the 
segmentation algorithm resulted in a false positive rate of 4.5% and a false negative rate of 
7.5% corresponding to a sensitivity and specificity of 93.0% (95% CI, 88.5% - 96.1%) and 
96.5% (95% CI, 93.0% - 98.6%), respectively. False negatives were often due to two or 
more cells in very close proximity that were not successfully separated by the algorithm or 
due to cells with very low-intensity far-red fluorescence. False positives were due to light 
from a very bright cell refracted off the edge of the microraft. The watershed segmentation 
method ultimately resulted in a sensitivity of 96 ± 16% in identifying cells with CellTracker 
Deep Red fluorescence and a false cell identification rate of 1.5 ± 9.0% (n = 401 microrafts). 
The watershed segmentation was most accurate when low numbers of cells were located on 
a microraft. For this reason, the data obtained from the watershed segmentation was only 
used to count T cells.
Cytotoxicity or cell killing was measured by summing the Sytox Green pixel intensity 
within the Hoechst fluorescence area on each microraft. Using the Hoechst positive regions 
on each microraft as a mask for the Sytox Green fluorescence greatly reduced spurious 
measurements due to debris and disintegrating cells and their fragments. The effector cell 
count and cytotoxicity information was recorded for each microraft at each time point to 
generate temporal traces of cytotoxicity corresponding to specific numbers of effector cells 
present.
Figure 4 shows the results of 2 microraft arrays analyzed in parallel. The first array (Figure 
4A-H) contained M1p-pulsed DCs as targets and the second array (Figure 4I-P) contained 
PR1-pulsed DCs. Because the assay was intended to identify individual highly cytotoxic T 
cells, the arrays were first analyzed to identify microrafts with 0, 1 or >1 CD8+ T cell 
(Figure 4A, I), and the increase in green fluorescence at each microraft was measured 
(Figure 4B, J). These general analyses showed that the T cells distributed evenly over the 
array, and there did not appear to be any particular regions on the arrays with abnormally 
strong increases or decreases in green fluorescence. Several different methods were 
considered to analyze the inter-microraft cytotoxicity. In the initial analysis, the microrafts 
were segregated into those with 0 T cells and those with 1 T cell (microrafts with >1 T cell 
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were excluded). The difference in green fluorescence at t = 6 h and t = 0 h was measured for 
each microraft. The differences in fluorescence across the arrays are shown (Figure 4C, D, 
K, L). This representation proved to be difficult to visualize and interpret. However, when 
the fluorescence differences observed in the 0 T cell microrafts were compared to the 
differences observed in the 1 T cell microraft, there was a statistically significant difference 
observed in the M1p array but not the PR1 array (Figure 4E, M). Since the assay monitors 
cellular processes over time, more information on a per T cell basis is available than the 
simple differences over 2 time points. The change in green fluorescence over time for each 
microraft was measured for microrafts with 0 T cells (Figure 4F, N) and 1 T cell (Figure 4G, 
O). While many microrafts exhibited similar rates of increase in green fluorescence, there 
were some microrafts that exhibited high rates of apparent cytotoxicity. To identify these 
microrafts, the median rate of green fluorescence ± 4 median absolute deviations for the 0 T 
cell microrafts in each array was calculated. The rate of green fluorescence increase for all 
microrafts with 1 T cell was obtained, and only microrafts with green fluorescence > 4 
median absolute deviations from the median at all time points were selected as “best killers”. 
A total of 55 microrafts met this criterion in the M1p array and 8 met the criterion on the 
PR1 array (Figure 4H, P).
Single CD8+ T cell cytotoxicity rates remain stable over 6 hours
In addition to identifying antigen-specific cytotoxic T cells for further characterization 
(Figure 4) the rate of target cell death throughout the array was analyzed with normalization 
to the number of target cells per microraft. Data from microrafts containing a single CD8+ T 
cell were clustered using the k-medioids algorithm. The population of M1p specific CD8+ T 
cells was clustered into 3 groups based upon rate of cytotoxicity (Figure 5A). Cytotoxicity 
was measured as the development of green fluorescence normalized to the blue fluorescence 
per microraft. Over the 6 h time course of the experiments, the rate of cytotoxicity for each 
cell remained relatively constant meaning that cells with high rates of cytotoxicity as 
measured over a 6 h time course could be identified within 2 h of the experiment (Figure 
5B).
Isolation and expansion of T cells based upon cytotoxicity
Individual CD8+ T cell expansion was performed on the original T cell culture by limiting 
dilution. Cells were diluted to an expected density of 1 cell per 2 wells into a 96-well plate 
and incubated for 3 weeks. The 96 most active T cells from the M1p array were sorted using 
the microraft release device into a 96-well plate and again allowed to clonally expand for 3 
weeks. The limiting dilution and microraft release experiments were performed twice. Of the 
192 microraft release procedures, 122 resulted in the single selected microraft being 
deposited into a well. From the two 96-well plates that received cells by limiting dilution, 4 
wells demonstrated T cell expansion; however, none of these clones demonstrated specificity 
for M1p by tetramer analysis (data not shown). Of the 122 wells with single microrafts, 3 
clonal populations were expanded. All 3 of these CD8+ T cell populations demonstrated 
high avidity binding to M1p/tetramer (Figure 6A-L). While the expansion efficiency of 
sorted cells was not high, it is comparable to that of peptide/MHC based FACS, which is the 
technique usually employed to isolate and clonally expand antigen-specific T cells. Initial 
studies with tetramer based FACS for clonal expansion reported expansion rates of 2 to 13% 
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of sorted cells.49 Limiting dilution, the gentlest clonal T cell expansion strategy employed, 
yielded a similar number of clones competent to expand as that yielded by our gelatin 
encapsulation and microraft release method. This similarity suggests that our antigen-
specific sorting method is not substantially harsher on T cells than limiting dilution, and that 
the overall low clonal expansion efficiency is more likely related to the health of the initial T 
cell culture. We do note that the tested T cell culture for these experiments had been 
stimulated and then cryopreserved for 8 months prior to use in the cytotoxicity and 
expansion experiments described in this paper. This prolonged cryopreservation and the 
resulting thawing of the T cell culture could have substantially influenced the surviving T 
cells’ ability to expand robustly. It is unlikley that the CellTracker Deep Red dye used to 
identify CTLs on the array impacted their long-term viability in culture since this dye, and 
the related compound CFDA SA (commonly referred to as CFSE) have been used 
extensively to measure primary T cell expansion for both in vitro and in vivo T cell 
functional experiments.50, 51 Using the device, we were able to isolate 1 CD8+ T cell every 
20 s based upon the cytotoxicity measurements. This method of single cell isolation is 
roughly 3× faster than micromanipulation, which has been used on microwell platforms 
previously, and it minimizes the risk of cross contamination by not repetitively using 
microcapillaries for cell transfer.46, 52
While the primary focus of this study was to develop the microraft array platform to identify 
antigen specific CTLs and expand clonal CTL populations (Figure 6), a secondary aim was 
to expand on the method to determine the sequence of the clonal CTL’s TCR because these 
data could be used for the development of immunotherapeutics. TCRs exist as heterodimeric 
protein complexes consisting of a TCRα chain paired with a TCRβ chain, which are 
expressed on the T cell’s surface. The paired chains bind with high affinity to the target 
peptide/MHC, which were in this instance the M1p/HLA-A*02:01 complex. The portions of 
the TCRα and TCRβ chains that impart the specificity of the interaction with the target 
peptide/MHC are known as the CDR3 regions. If the CDR3 regions and flanking V and J 
segments of the TCRα and TCRβ chains are known, full-length transgenic TCR constructs 
can be produced and transfected into primary human T cells to change their specificity 
towards the target peptide/MHC. This approach could have a broad application in cancer 
immunotherapy where a cancer patient’s T cells could be transduced with a transgenic TCR, 
containing TCRα and TCRβ chain sequences, that targets a cancer-specific peptide/MHC 
complex.53
We performed TCRα and TCRβ CDR3 sequencing on the sorted and expanded T-cell clones 
obtained in our cytotoxicity assay. RNA was extracted from small aliquots of the clonal 
populations, and the CDR3 regions of the TCRα and TCRβ chains were amplified for 
sequencing using a multi-primer (to enable amplification of all potential flanking V and J 
segments) RT-PCR protocol modified from single-cell TCR sequencing methods. The CDR3 
regions, and their associated flanking V and J segments, for TCRβ chains was determined 
for all 3 M1p/HLA-A*02:01 specific clonal populations, and the TCRα V, CDR3 and J 
sequences were determined for 2 of the clones (Table 1). With these data, it would be 
possible to produce viral vectors containing full-length TCRα and TCRβ chains that could 
be transduced into primary T cells for targeting influenza infected cells expressing the M1p/
HLA-A*02:01 complex.
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Conclusions
In conclusion, we have developed an automated microraft array that can measure the 
cytotoxic ability of individual CD8+ T cells and isolate selected cells for clonal expansion 
and further analysis - in this case tetramer based avidity measurements and TCRα and 
TCRβ CDR3 sequencing. This study provided us with several insights into CD8+ T cell 
mediated cytotoxicity.
When examined at a single T cell level there is tremendous heterogeneity of cytotoxicity. 
Even though 48.4% of the tested culture was M1p specific (Figure 3A), single cell analysis 
showed no clear demarcation between “antigen-specific” and non-specific CD8+ T-cells. 
Rather there was a broad range in cytotoxicity (Figure 5A), which emphasizes the 
differences between static measurements of TCR avidity (via peptide/HLA tetramer) and 
functional analysis. While the rates of cell mediated cytotoxicity varied greatly among the T 
cell population, individual CD8+ T cells maintained a relatively consistent rate of target cell 
death throughout the 6 h time frame of the assay. This consistent rate of cell killing enabled 
the identification of the most highly cytotoxic individual CD8+ T cells within 2 h (Figure 5). 
The ability to determine the activity of small numbers of effector T cells in very short time 
scales could have a significant impact on immune monitoring as T cell therapies are 
developed for clinical use. Such assays could be used to screen T cells cultures for antigen 
specificity against multiple antigens to reduce the risk of off-target cytotoxicity that has been 
observed in early T cell therapy studies.54-56
This automated platform can be modified to address other issues in immunology. While the 
pilot study was intended to rapidly identify “best killers” in an enriched population, the array 
geometry can be easily modified to identify rare cytotoxic T cells. Microraft arrays having 
individual microrafts measuring 50 μm × 50 μm with a 20 μm gap have been fabricated on a 
2.5 cm × 2.5 cm array yielding >125,000 microrafts on a single array, and the array size can 
also be scaled to further increase the number of elements, which could enable the 
identification and subsequent cloning of rare tumor antigen-specific CD8+ T cells.
While modifying the array geometry and assay time scale could allow for discovery of rare 
antigen specific T cells, the array can also be used to interrogate the effects of multiple 
cellular populations interacting at the same time. While this study only interrogated 2 cell 
populations, further cells types, such as myeloid derived suppressor cells (MDSC)57 and 
regulatory T cells (Treg)58 could also be added to the arrays to evaluate their relative abilities 
to inhibit cytotoxic T cell function over a broad spectrum of conditions. Because the assay 
also measures target cell death, as opposed to a surrogate marker like T cell CD107 
expression, studies investigating target cell resistance to T cell mediated cytotoxicity could 
also be designed.
In addition to measuring cytotoxicity, experiments on the microraft arrays could also be 
designed to measure individual T cell proliferation over a period of a few days. Proliferation 
would also be expected to be an antigen-specific response; however, the measurement of T 
cell division would provide a general read out for both CD8+ (cytotoxic) and CD4+ (helper) 
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responses with the subsequent possibility of sorting clonal populations of antigen specific 
CD8+ and CD4+ T cells.
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Figure 1. Microraft based selection of cells
The microraft array in these studies is a 2.5 cm × 2.5 cm array containing 70 × 70 
microrafts. Each microraft is 200 μm × 200 μm × 200 μm in outer dimensions and separated 
from adjacent microrafts by a 100 μm gap. The cassette walls surrounding the array are 1 cm 
high allowing for excess media to be applied over the microrafts (Figure 1A, B). 
Fluorescence from each microraft can be measured. In this example a “green cell” is 
identified (Figure 1C). The array is encapsulated in gelatin, and the needle release 
mechanism pushes through the PDMS to release the identified microraft (Figure 1D). The 
magnetic wand attached to the microscope objective captures the released microraft (Figure 
1E). The wand is moved to a well of a 96-well plate where a block magnet pulls the 
microraft to the bottom of the well (Figure 1F). A 3 × 3 section of the array is shown using 
bright field microscopy (Figure 1G). The needle release ejected the microraft in the middle. 
In this example 5 needle penetrations were used to demonstrate the accuracy of the device 
and to show that the elastomeric PDMS readily reseals without loss of media despite 
repeated puncturing (Figure 1H).
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Figure 2. Design of T cell mediated cytotoxicity assay
The microraft array was designed to identify the best M1p specific CTLs. The arrays were 
loaded with Hoechst labeled “target” cells (peptide pulsed DCs) at a density of 30 cells per 
microraft and co-incubated with CTLs from an M1p culture at a mean density of 1 cell per 
microraft. (Figure 2A). Over time target cells die and take up Sytox Green that is present in 
the media (Figure 2B). Microrafts with the greatest increase in green fluorescence are 
identified as likely having the most cytotoxic T cells (Figure 2C). Both the targets and T 
cells distribute into the microrafts according to the Poisson distribution. A 5 × 5 microraft 
array shows multiple different ratios of cells throughout the array (Figure 2D, E). 
Fluorescence images for 2 of the 4900 microrafts are shown at 1 h time points (images were 
collected every 30 min). A microraft with 1 CTL (red cell) shows increased killing (green 
fluorescence) over time (Figure 2F), and another microraft without a CTL shows no killing 
over time (Figure 2G).
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Figure 3. M1p specific T cell culture
A T cell culture was generated against the influenza M1p antigen, and the percentage of 
M1p-specific CD8+ T cells was enumerated using M1p/HLA-A*02:01 tetramers and a 
negative control HLA-A*02:01 tetramer, along with an anti-CD8 antibody and a lineage 
marker mix of CD4, CD14, CD16 and CD19 antibodies. Tetramer staining was analyzed by 
gating on live cells (DAPI negative), lymphocytes (FSC vs SSC), and CD8+Lineage− cells. 
Only the CD8+Lineage− cells are shown on the plots. Over 99% of the cells that fell in the 
live lymphocyte gates were CD8+Lineage−. Non-specific binding to the negative control 
tetramer was low (0.05% of CD8+ T-cells), while 48.4% of CD8+ T-cells had high avidity 
interactions with the M1p/HLA-A*02:01 tetramer (Figure 3A). The culture also 
demonstrated antigen specific cytotoxicity against M1p pulsed autologous DCs compared to 
PR1 pulsed autologous DCs (Figure 3B). For the cytotoxicity assay, the FSC vs SSC plot 
was gated to remove debris in the lower left hand corner, and DDAO-SE positive target cells 
(DCs) were selected on a DDAO-SE vs CMFDA plot. The percentage of dead target cells 
shown is the percentage of DDAO-SE positive DCs that also stained positive with the 
Fixable Violet Dead Cell Stain.
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Figure 4. Overall analysis of cytotoxicity on microraft arrays
Two arrays are compared: the first with M1p-pulsed DCs as targets (Figure 4A-H) and the 
second PR1-pulsed DCs as targets (Figure 4I-P). The fluorescence measurements for each 
microraft are shown in processed 70 × 70 array images (Figure 4A-D, 4I-L), where each 
box represents the appropriate fluorescent measurement for 1 microraft. T cells distribute 
evenly across the arrays with some microrafts having 0, some having 1 and some having >1 
CTL present, measured by enumerating the numbers of segmented far-red labeled cells per 
microraft (Figure 4A, I). After 6 h, both arrays have a modest increase in green fluorescence 
(cell death) throughout the entire array (Figure 4B, J). Comparisons were made between the 
green fluorescence produced in microrafts with 0 CTLs and those with 1 CTL. In these 
representations only microrafts with the appropriate numbers of CTLs (i.e. 0 or 1) are 
colored. Quantified green fluorescence at t = 6 h (minus green fluorescence at t = 0 h) for 
microrafts with 0 CTLs (Figure 4C, K) and 1 CTL (Figure 4D, L) is shown with the other 
microrafts represented in black. The differences in mean fluorescence change between 
microrafts with 0 and 1 CTL were small, but statistically significant for the M1p array 
(Figure 4E) but not the PR1 array (Figure 4M). The array can measure the change in green 
fluorescence per microraft during the time course of the experiment. The fluorescence over 
time traces for all of the microrafts with 0 CTLs (Figure 4F and N) and 1 CTL (Figure 4G, 
O) are shown. The microrafts with the “best killers” were identified as having 1 CTL with 
green fluorescence > 4 median absolute deviations above the median (denoted by the light 
blue bars) at all time points. There were 55 of these microrafts on the M1p array and 8 on 
the PR1 array (Figure 4H, P).
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Figure 5. Single CD8+ T cell cytotoxicity rates
Data from microrafts containing a single CTL were clustered using the K-medoids 
algorithm. The data were clustered into three groups based on the total change in green 
fluorescence (Sytox Green) from 0 to 6 h normalized to the area of target cells (Hoechst+ 
fluorescence). These clusters were labeled as “Low Cytotoxicity” (n = 580), “Medium 
Cytotoxicity” (n = 603), and “High Cytotoxicity” (n = 160) (Figure 5A). A linear fit was 
performed on the first 2 h of the fluorescence/cytotoxicity data (first 5 time points). There 
was a statistically significant difference in the slope of the fits for all identified clusters. This 
indicates that it may be possible to separate Low, Medium and High cytotoxicity after the 
first 2 h of a cytotoxicity assay (Figure 5B).
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Figure 6. Isolation and expansion of T cells based upon cytotoxicity
The CTLs from the M1p array with the greatest measured cytotoxicity were sorted using the 
microraft release device into a 96-well plate and allowed to clonally expand for 2 weeks. 
Three clones expanded: CTL3-MR-B8 (Figure 6A-D), CTL3-MR-D10 (Figure 6E-H), and 
CTL-MR-F9 (Figure 6I-L). The t = 0 and t = 6 h fluorescence for each of their respective 
microrafts are shown (Figure 6A-B, E-F, I-J). After clonal expansion TCR avidity for M1p/
HLA-A*02:01 tetramer was measured. Negative tetramers were again used to define the 
tetramer gate (Figure 6C, G, K), and all 3 clonal populations had high avidity interactions 
with M1p/HLA-A*02:01 tetramer (Figure 6D, H, L). Tetramer staining was analyzed by 
gating on live cells (DAPI negative), lymphocytes (FSC vs SSC), and CD8+Lineage− cells. 
Only the CD8+Lineage− cells are shown on the plots.
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Table 1
Seven T-cell clones were expanded using either microraft selection (denoted -MR-) or limiting dilution 
(denoted -LD-). Three of 3 MR selected clones expressed high avidity TCRs towards M1p/HLA-A*02:01 
tetramer. The V segment, CDR3 sequence, and J segment for both the TCRα and TCRβ chain were sequenced 
on the first 2 clones, but only the TCRβ sequence could be determined for the third clone. None of the clones 
identified by LD expressed high avidity TCRs. Therefore, their TCRs were not sequenced.
Clone M1p Tetramer TCRα TCRβ
CTL3-MR-B8 Positive V19-CALSEAGTGGSYIPTF-J6 V19-CASSMFVGQPQHF-J1-5
CTL3-MR-D10 Positive V41-CAVSVEETSGSRLTF-J58 V19-CASSFFHNNEQFF-J2-1
CTL3-MR-F9 Positive ND V19-CASSIRSSYEQYF-J2-7
CTL3-LD-B2 Negative ND ND
CTL3-LD-C4 Negative ND ND
CTL3-LD-C8 Negative ND ND
CTL3-LD-G3 Negative ND ND
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